<DOC>
	<DOCNO>NCT01353456</DOCNO>
	<brief_summary>Recently , multimodal approach postoperative pain control advocated.Combinations traditional novel pharmacological agent administer , aim improve analgesia , spare opioid consumption , minimise adverse effect , improve postoperative bowel function colorectal surgery . One novel agent suggest dexmedetomidine . It selective alpha-2 adrenoceptor agonist , demonstrate anaesthetic , sedative analgesic-sparing effect . Furthermore , significant reduction postoperative morphine consumption use patient-controlled analgesia ( PCA ) achieve dexmedetomidine administer operation . The drug also reduce cate-cholamine secretion , thereby reduce stress lead modest reduction heart rate blood pressure , may particularly beneficial patient cardiovascular disease , respiratory rate affect . In study , investigator would like evaluate analgesic effect dexmedetomidine , administer intraoperatively morphine , follow postoperative PCA morphine infusion , postoperative pain open laparoscopic colorectal surgery . Cyclooxy-genase-2 ( COX-2 ) inhibitor rescue intramuscular pethidine also incorporate part multimodal analgesia regimen . Good pain control help decrease cardiovascular complication . Emerging data suggest key role soluble CD40L inflammatory mediator atherosclerotic lesion progression . The investigator would like evaluate effect analgesic regimens soluble CD40L peri-operatively . The investigator hypothesize intraoperative dexmedetomidine reduce postoperative pain improve recovery outcomes .</brief_summary>
	<brief_title>Multimodal Analgesic Using Morphine COX-2 With Without Dexmedetomidine Colorectal Surgery</brief_title>
	<detailed_description>PROCEDURES : Patients approach pre-admission clinic general ward operation . The analgesic modality explain patient recruit study s/he agree . Patient randomise one two group receive intraoperative morphine dexmedetomidine postoperative PCA morphine ( D ) , intraoperative morphine postoperative PCA morphine ( M ) . Randomisation , blinding , preparation dexmedetomidine placebo Patients undergo open laparoscopic colonic rectal surgery stratify randomisation . For type operation ( colonic rectal ) , randomisation base use block 5 patient ensure group equal sample size . A computer-generated random sequence use select allocation order . Both patient investigator blind allocated analgesic modality , i.e . administration dexmedetomidine . Dexmedetomidine normal saline ( placebo ) prepare clinical staff participate observation data analysis . For group D , dexmedetomidine prepare add 2ml drug ( 100μg/ml ) 48ml 0.9 % sodium chloride injection , make total 50ml . The final concentration administration thus 200μg 50ml , i.e . 4μg/ml . For group M , syringe 50ml normal saline prepare placebo . As dexmedetomidine placebo look 50ml clear liquid syringe , patient investigator blind substance administer . Preoperative care : The patient assess pre-admission clinic general ward . Blood soluble CD40L routine investigation take . Bowel preparation start one day operation . Patient fast since midnight operation . Anaesthesia intraoperative care : Both group patient anaesthetise accord protocol follow : Patient receive sedative premedication . On arrival operation theatre , 16-gauge intravenous cannula place local analgesic . Pulse , pulse oximetry non-invasive blood pressure measurement check every 5 minute throughout operation . Propofol 2mg/kg , fentanyl 1.5μg/kg atracurium 0.5mg/kg use general anaesthesia induction . Anaesthesia maintain mixture isoflurane , air oxygen . Isoflurane concentration titrate optimal heart rate blood pressure anaesthesiologist . Thermal blanket infusion fluid warmer use aim maintain core body temperature 35.5 37.5 degree Celsius . A urinary catheter insert monitor urine output . Intermittent pneumatic compression device apply low limbs deep vein thrombosis prophylaxis . At discretion anaesthesiologist , hypotension treat intravenous ephedrine phenylephrine . Hypertension tachycardia treat isoflurane 2 % end-tidal concentration ( ~1.5 MAC ) . If persist , beta-blockers labetalol arterial vasodilator hydralazine may give . Isoflurane switch closure inner layer wound . Reversal achieve intravenous neostigmine 50μg/kg atropine 20μg/kg operation . Patient transfer recovery room monitoring least 1 hour . Analgesic modality pain assessment : Procedures two analgesic modality describe : Group D : intraoperative morphine dexmedetomidine postoperative PCA morphine . Patient receive loading dose 1μg/kg ( 0.25ml/kg ) intravenous dex-medetomidine 10 minute induction , follow continuous infusion rate 0.5μg/kg/h ( 0.125ml/kg/h ) wound closure . Bolus dose 0.1mg/kg morphine sulphate give intravenously prior incision . At third forth hour , morphine sulphate 0.1mg/kg may give divide dose titrated patient 's response . On arrival recovery room , boluses 2mg intravenous morphine give every 5 minute NRS pain score less 4 . A PCA machine connect . The machine configure give 1mg morphine time lockout duration set 5 minute . No basal infusion give maximum dose limit 0.1mg/kg per hour . Group M : intraoperative morphine postoperative PCA morphine . All procedure Group D patient follow , dexmedetomidine administration replace placebo ( normal saline ) volume rate . Both group : Starting postoperative day 1 , patient resume fluid diet , oral celecoxib 200mg give twice daily 3 day discharge , whichever early . From day 4 onwards , one tablet dologesic ( paracetamol plus dextropropoxyphene ) give every 4 hour need discharge . From postoperative day 0 , rescue analgesic form intramuscular pethidine 0.5mg/kg prescribe every 4 hour necessary . During administration PCA morphine , respiratory rate , SpO2 sedation score monitor every hour ; blood pressure pulse , numerical rating scale ( NRS ) pain score rest cough , cumulative dos tries/goods , well side effect record every 4 hour . Patient see anaesthesiologist every day ass adequacy analgesia . PCA morphine administer least 2 day . On postoperative day 2 , NRS pain score cough less 4 clinically low morphine consumption , PCA stop ; equal great 4 , still high PCA consumption , continue . Assessment repeat daily . If NRS pain score cough remain 4 day 5 , patient evaluate complication manage discretion anaesthesiologist . After PCA morphine stop , NRS pain score rest cough , dose frequency rescue analgesia use chart day discharge . Postoperative care assessment : Early mobilisation encourage operation . On postoperative day 1 , patient put fluid diet . The surgical team responsible postoperative assessment , record daily gastrointestinal function ( bowel sound , flatus bowel opening ) , postoperative complication ( ) readiness discharge patient ( good pain control oral analgesic , ambulatory , resumption bowel function , i.e . stool flatus , 2 3 feed without vomit abdominal distension ) . Blood soluble CD40L routine investigation take post-operative day 2 . Patient 's satisfaction analgesia ask use NRS zero 10 upon discharge . DATA COLLECTION : The follow data collect : - Demographics - Time admission - Type colorectal surgery incision - Intraoperative vital sign ( blood pressure , pulse , pulse oximetry ) - Estimated intraoperative blood loss - Volume intraoperative fluid/blood infusion - Duration anaesthetic/analgesic procedure surgical procedure - Duration surgical procedure - Time end surgical procedure extubation - Tries good PCA use - Cumulative morphine consumption - NRS pain score rest cough vital sign upon recovery , hourly 4 hour , 4-hourly PCA morphine 5 day , daily afterwards discharge - Dose frequency rescue analgesic ( IM pethidine ) use - Side effect analgesic , ( pruritis , dizziness , nausea , vomit , etc . ) - Time recovery bowel function ( bowel sound , flatus bowel opening ) - Time recovery food intake ( fluid , semisolid solid diet ) - Time ambulation ( bed rest , sit , sit bed , walk aid , walk without aid ) - Surgical anaesthetic complication , ( ileus , perineal abscess , wound infection , urinary retention , etc . ) - Time discharge - Patient 's satisfaction upon discharge - Persistent pain 6 month operation - Survival status 6 12 month operation - Soluble CD40L preoperatively post-operative day 2 If , certain time point operation , patient unable manage accord protocol due reason development complication , data collect . DATA ANALYSIS : The intention-to-treat principle use . In word , patient include remain designated group data analysis even change surgical anaesthetic/analgesic management , long open laparoscopic abdominal incision operation . Statistical method use : - Intraoperative vital sign , estimate blood loss , duration anaesthetic/analgesic surgical procedure , time extubation , try good PCA use , cumulative morphine consumption , dose frequency rescue analgesic use , time recovery bowel function , food intake ambulation , time discharge : Student 's t-test - NRS pain score , patient 's satisfaction : Mann-Whitney U test - Side effect postoperative complication : binary logistic regression</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>ASA I III Age 18 80 year Scheduled elective open laparoscopic colonic upper rectal resection Queen Mary Hospital Hong Kong Extended resection involve organ liver urinary bladder Known drug allergy alpha2 agonist , opioids , nonsteroidal antiinflammatory drug ( NSAIDs ) include COX2 inhibitor sulphonamides Regular use clonidine , methyldopa , opioids psychiatric drug Alcohol drug abuse Known history second third degree heart block , ischaemic heart disease , valvular heart disease , heart failure Known history pulmonary embolism deep vein thrombosis Known history sleep apnoea syndrome Impaired renal function , define preoperative serum creatinine level 120µmol/L Impaired hepatic function , define preoperative serum albumin level le 30g/L Impaired retard mental state Not selfambulatory operation Difficulties use patientcontrolled analgesia BMI &gt; 35kg/m2 Pregnancy Patient refusal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Ambulation</keyword>
	<keyword>Side effect</keyword>
	<keyword>Serum sCD40L</keyword>
	<keyword>Bowel function</keyword>
	<keyword>Postoperative pain</keyword>
</DOC>